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One  of  the  main  problems associated with  the  sterilization of  plasma and 
plasma fractions is the inactivation of the serum hepatitis virus.  Ideally, this 
should  be  accomplished  with  the  minimal  alteration  of  the  serum  proteins. 
If  the  extent  of  alteration of  these  proteins  is too  great,  the  possibility that 
they may  become  antigenic in  man  must  be  considered.  Ethylene  oxide gas 
which has been used as a  sterilizing agent for foods, antibiotics, and medical 
plastics has been considered for the  sterilization of bacteria and viruses. The 
basic  reaction  is  an  alkylation of  reactive  groupings  in  the  protein  such  as 
lysine and histidine. The  data presented in the present report deal with anti- 
genicity  studies  in  humans  and  rabbits  of  several  ethylene  oxide-treated 
human  sera.  As  will  be  shown,  definite  "delayed  cellular  hypersensitivity" 
reactions were produced in humans. 
Materials and Methods 
The  ethylene oxide  (E-O)-treated materials were  supplied by Courtland Laboratories, 
Los Angeles, California and will be referred  to as CLM-treated sera. A special preparation, 
500S, for injection into humans,  was obtained from a donor known to be free of serum hepa- 
titis. 
After withdrawal of 50 ml. of blood, the volunteers were skin-tested with 0.1  ml of the 
different  materials, and  then injected intramuscularly 5  times over a  10 day period with 
solutions of various amounts of the CLM-treated serum. The bleeding and skin testing were 
repeated 10 days and 3 weeks after the last injection. The serum was stored in the cold with 
1:10,000 "merthiolate" and 0.25 per cent phenol  as preservatives. The skin reactions were 
read after 15 to 20 minutes and after 24 hours.  The pre- and postimmunization sera were 
analyzed by several in vitro and in vivo procedures. 
The  agar diffusion  techniques  of Preer  (1)  and  Ouchterlony  (2)  employing undiluted 
antiserum and varying dilutions of the antigen (undiluted, 1-10,  1-100,  1-1000,  1-10,000, 
and 1-100,000) were set up at 25  ° and at 0°C. 
* Supported by the Department of the Army, Office of the Surgeon  General,  Contract 
Nos. DA-49-007-MD-248 and DA-49-193-MD-2113 and United States Public Health Service 
Grants E  1258 and E 3514. 
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The microprecipitin technique for analysis of human sera as developed by Heidelberger 
and MacPherson (3)  using 3.0 ml. of serum and 1.0 ml. of the indicated dilutions of CLM- 
treated serum was set up at 0 ° and observed for 14 days before analyzing the mixtures. 
For studies of passive systemic anaphylaxis guinea pigs weighing 200  to  250 gm.  were 
given intraperitoneal injections of 1, 2, 4, or 5 ml. of the serum obtained from volunteers 105 
and 111.48 hours later, the guinea pigs were injected intravenously with 2 ml. of the CLM 
serum,  and observed for signs of anaphylaxis. 
The sensitive passive cutaneous anaphylaxis test (PCA)  of Ovary  (4)  was performed in 
guinea pigs weighing about 250 gm.  Guinea pigs were given an intracutaneous injection of 
0.1 ml. serum obtained from the various bleedings. 3 hours later, the guinea pigs were given 
an intravenous injection of 1.25 ml. of CLM serum and dye (1 ml. serum and 0.25 ml. 1 per 
cent Evans blue dye).  Any blueing of  the injected sites was recorded. 
Biopsies of immediate and delayed skin reactions of donors and recipients  1 were obtained 
by sterile surgical procedures and fixed in formalin for 24 hours before histological sectioning 
and staining with hematoxylin and eosin. 
The transfer of the delayed hypersensitivity reactions by viable and killed leukocytes was 
performed according to the procedures outlined by Lawrence a  a/. (5). Leukocytes harvested 
from  100 ml.  of peripheral blood of  the 2 best reactors were injected subcutaneously in a 
volume of 1 to 2 ml. into the forearm of normal recipients. 24 hours later the recipients were 
skin-tested on the opposite  forearm.  Skin reactions were  observed for  72  hours and some 
biopsies obtained after 24 hours. Extracts of leukocytes were obtained by freezing the cells in 
a  dry ice-acetone mixture and thawing them at 37°C.  The above was repeated 7 times, and 
the cell extracts centrifuged in the cold before injection into volunteers. 
Six male albino rabbits weighing about  2.5  to  3  kg.  were  immunized with a  complete 
adjuvant mixture of the CLM 500S preparation containing 25 rag. protein per ml. The mixture 
contained equal parts of serum and equal volumes of a mixture of bayol F  (9 parts) and arlacel 
C (1 part) (6, 7). Dead mycobacteria (1 mg. per ml.) were also included. The first injection of 
1 ml. was made in the hind foot-pads.  2 weeks later 1 ml. of adjuvant  was injected intra- 
muscularly in the hind quarter. The rabbits were bled  weekly, beginning 3 weeks after the 
last injection. The sera were tested qualitatively and the high titered sera  were pooled. The 
rabbit antisera were studied by several agar diffusion techniques  based on the Ouchterlony 
method. Dilutions of the CLM serum (1-10,  1-100,  1-1000) and normal human serum were 
reacted with the anti-CLM 500S serum in veronal-giycine-agar medium  (8).  In additional 
studies, the agar was made up to contain 25 per cent normal human serum (9).  The center 
wells were filled with antisera and the outside wells with dilutions of serum or plasma. 
Rabbit antisera against human serum albumin and human gamma globulin were the same 
as used in previous publications (10). They were prepared by intravenous injections of alum- 
precipitated  proteins.  The  antisera were  calibrated  by  the  quantitative  immunochemical 
techniques developed by Heidelberger and coworkers  (11). Nitrogen content of all samples 
was determined by the Markham modification of the micro Kjeldahl method (12). 
RESULTS 
Table I presents the data on the skin reactions observed before and 10 days 
after immunization of individuals injected with different  amounts of CLM- 
treated  serum.  Some  individuals showed  positive "skin reactions"  to  the 
materials before immunization. The reactions were slightly  erythematous and 
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had some speckled areas. The reactions were gone in 1 to 2 hours, and did not 
return  the following day.  Mter  the fourth injection,  several individuals had 
flare-up reactions at the initial skin test site of the CLM serum (Fig.  1). The 
dotted markings indicate the size of the erythema the night before the reaction 
was  recorded.  Other  observations  noted  during  the  immunization  were  as 
follows:  Volunteer  104  observed  that  the  day  after  the  last  injection, the 
original CLM serum site was itching and measured 9 ram. in diameter. Volun- 
TABLE  I 
Results of Skin Testing with CLM Serum* 
Preimmunization  I0 days postimmunlzation 
Volunteer 
No.  CLM serum  0.15 ~  NaC1 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
CLM 
serum in- 
jected per 
injectlon 
0 
10~; 
0 
305 
205 
305 
225 
155 
305 
0 
25~ 
ELM serum  0.15  ~ NaCI 
mg  __  __Imm~d!a~e 
5  0  ]  22  I 
5  0  /  20  I 
5  0  24 
5  0  40 
10  0  5 
10  0  22  24 
10  0  18  20 
10  0  20  30 
25  0~  25  18 
25  0  31  15 
25  8:~  17  xx 
25  0  30  15 
24 hrs.  48 hrs.  Immediate  t  24 hrs. 
J 
0  3 
5  5 
0  0 
0  0 
0  5 
ao  11o 
10  4  0 
10  i  0 
10  I  0 
10  0 
10  xx 
10  0 
23  25 
32  50 
0  10 
8  0 
22  30 
X 
0 
35 
0 
0 
20 
0 
48 hrs. 
x, large red swollen area. 
xx, not read. 
* All values given in millimeters (diameter of reaction); all  reactions were erythematous. 
Very pale reaction. 
teer 105  reported that  4  days after the last injection, the  skin test site was 
warm  and  measured  21  X  40  mm.  Volunteer  108  reported  an  erythema 
16  mm. in diameter  the  day after the last injection. Volunteer 111  reported 
that 4 hours after the last injection, the original skin test site had flared up to 
20 ram. diameter. It was red and itching. The results of the skin tests observed 
10 days after the last injection indicated that the CLM serum was inflamma- 
tory and produced some immediate reactions which faded rapidly. Mter 2 to 4 
hours there was a gradual return of a  positive reaction to the CLM material. 
This sort of behavior was repeated at each time of testing for 1~  years and 
is  shown again with  the data obtained at the 3  week testing period  (Table 
II). The type of delayed reaction usually observed is shown in Fig. 2. 1032  IMMUNOLOGIC  STUDIES 
The  most  sensitive reactors  were  tested  with  1-100  and  1-10  dilutions of 
the CLM serum as well as with undiluted material. The behavior was always 
the  same, i.e.,  an  immediate  reaction which was  gone  in  1 hour, followed by 
a  gradual return of the delayed type of reaction which was visible after about 
6  hours.  The  immediate reaction  appears  to  be  related  to  the  fact  that  the 
CLM serum behaved as a  "histamine liberator." This was observed by inject- 
ing guinea pigs intravenously with Evans blue dye and then injecting 0.1  ml. 
of  the  CLM  serum  intradermally.  Definite  blueing  reactions  occurred  with 
serum dilutions as low as 1: 10,000. 
TABLE II 
Results of Skin Testing Volunteers  with CLM Serum 3 Weeks after Last Injection* 
Volunteer No. 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
Dilution injected 
intradermally 
1-10 
1-100 
Undiluted 
1-10 
1-10 
Undiluted 
1-100 
Undiluted 
I 
* All values given in millimeters 
CLM serum  0.15  M NaCI 
Immediate  24 hr.  rea  Immediate 
reaction  ction  reaction 
20  10 
0 
25 
40 
0 
25 
30 
25 
35 
30 
35 
40 
20 
25 
5 
15 
25 
15 
13 
25 
0 
10 
0 
24 hr.  reaction 
0  2 
0  0 
0  0 
0 
0 
0 
10 
0 
5 
5 
0 
0 
:liameter of reaction)  of erythema reaction. 
Biopsies of  the  early and  24  hour  reaction  skin  test  sites  were  examined 
histologically.  9- The  immediate reaction was mostly of an acute inflammatory 
nature and consisted mainly of polymorphonuclear cells. The 24 hour reaction 
shown in Fig. 3 indicates a heavy perivascular lymphocytic infiltration without 
vessel wall damage. This same sort of behavior was present in biopsy sites of 
other volunteers. The immediate type reaction interfered with the interpreta- 
tion of the results obtained in Prausnitz-Kustner reactions. ~o  ml. of various 
bleedings from  the  sensitive individuals was  injected  intradermally into  the 
forearm of normal individuals. 24 hours later these sites, as well as uninjected 
areas  of  the  opposite  forearm,  were  challenged  with  dilutions  of  the  CLM 
The author wishes to thank Dr. J. J. Vazquez of the University of Pittsburgh Medical 
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serum.  3 No differences in skin reactions were observed between the sensitized 
and  the  unsensitized  areas.  When  the  sera  from  the  sensitized  individuals 
were  analyzed for  antibody  by  the  in  v/fro  and  in  vivo  methods mentioned 
above, none was detectable. 
Attempts  to  transfer  this  delayed cellular sensitivity to  normal  recipients 
were  successful with either viable leukocytes or extracts of the lymphocytes. 
When  the recipients of the cells or extracts of cells were challenged intrader- 
mally they exhibited a  reaction pattern similar to that of the sensitive donors, 
TABLE HI 
Skin Reaaions in Normal Recipients of Lenkocyge~  fiom Sensitive Donors*, 
Volunteer No. 
105 
105 
111 
111 
111 
105 
105 
111 
State of 
leukocytes 
Dead 
Dead 
Viable 
ac 
cc 
Recipient 
G.O. 
R.F. 
A.N. 
M.R. 
T.T. 
Immediate 
15 
30 
35 
25 
35 
o§ 
Time of reaction 
4 hrs.  24 hrs. 
12 
20 
15 
11 
35 
35 
20 
30 
2O 
16§ 
30 
40 
35 
C.C. 
J.M. 
L.M. 
15 
25 
20 
10 
o§ 
10 
15 
10 
4~ hrs. 
40 
20 
0 
0 
0 
10§ 
15 
20 
20 
* Recipients received leukocytes harvested from 100 ml. of whole blood. 
2~ All reactions reported are diameter of erythema after injection of 0.1 ml. of undiluted 
CLM serum. 
§ Observations  in  tuberculin-negative recipient  after  transfer  of  leukocyte  extracts. 
Purified protein derivative used for skin testing. 
i.e., a  transient immediate reaction followed by a  return of a  delayed reaction. 
Table HI gives the detailed data obtained with several recipients. In addition 
to  the  transfer  of  sensitivity to  the  CLM  serum,  sensitivity  to  tuberculin 
(PPD) was transferred to one recipient. The donor was tuberculin-positive and 
the recipient was tuberculin-negative before the transfer of the cells. 
The histological appearance of the 24 hour reaction area is shown in Fig. 4. 
Here too, there is mainly a  perivascular lymphocytic infiltration. 
The  results  mentioned  so  far  would  indicate  that  we  are  dealing  with  a 
definite  immune  response in  humans  against  ethylene  oxide-treated human 
a The recipients of the serum injections were skin tested a year later and it was noted that 
they bad become "delayediy hypersensitive" from the intradermal injections. 1034  IMMUNOLOGIC  STUDIES 
serum.  The  type  of  reaction  is  certainly  compatible  with  the  tuberculin, 
cellular,  or  delayed reaction.  Several  manifestations  of  the  reaction  such  as 
(a)  absence of detectable antibody,  (b)  time of appearance of gross reaction, 
and (c) the histological appearance of the sites, all point towards a true delayed 
type reaction. 
The results of the immunochemical studies with antisera against the CLM- 
treated human serum indicate that extensive alteration occurred in the serum 
0  CLM  SERUM  ALB. 
160-  •  HSA  (fr.  ~) 
V  HSA-CLM 
140-  I~  PLASMA  ALB. 
120- 
I00- 
80- 
60- 
40- 
20- 
I  I  I  I  I  I  I  I 
5  I0  15  20  25  50  35  40 
ug.  N  HSA  ADDED  PER  ML.  ANTI-HSA  SERUM 
TEx¢-FIo. 1.  Homologous and  cross-precipitation reactions with  rabbit  anti-human 
serum albumin serum (dilution 1-5). O,  CLM serum albumin in  CLM 500S serum; 0, 
Normal human  serum albumin (fraction V);  V,  Normal  human serum albumin treated 
mildly with ethylene oxide; Y, Serum albumin in normal human plasma preparation. 
proteins during the sterilization procedures.  Fig.  5 shows the expected multi- 
plicity of antibodies produced against the 500S CLM serum. When the diffusion 
in  agar was performed in  the presence of normal human  serum  two  distinct 
bands still appeared (Fig. 6). This would indicate that at least 2 entirely new 
modified serum proteins were present in the preparation. The extent of their 
alteration was such that the rabbit antibodies against them did not react with 
normal human serum. That extensive alteration did occur was also shown by 
the  decreased  reactions  of  the  CLM  serum  albumin  with  rabbit  antisera 
prepared against human serum albumin (Text-fig. 1),  and human gamma glob- 
ulin.  The HSA-CLM in  the figure refers  to  human  serum  albumin  that was pA~rL ~.  ~AtUU~g  1035 
treated with E-O under mild conditions; the plasma albumin curve was ob- 
tained with appropriate dilutions of a normal untreated human plasma prepa- 
ration. 
DISCUSSION 
The present investigation was undertaken mainly to learn whether a certain 
ethylene oxide--treated human serum could be antigenic in man. Although it 
has  beeD shown  that  chemically modified proteins  can  be  antigenic  in  the 
homologous animal (13), the extent of modification was assumed to be minimal 
in this preparation. Earlier preparations of E-O-treated serum and plasma did 
not  show any change  in  electrophoretic behavior and  did not produce any 
reactions upon infusions into man (14). However, the extent of modification in 
this special serum 500S  due to alkylation of lysine and histidine groups was 
extensive. This modification was confirmed by the poor reactions of the 500S 
serum  with antiserum produced against  human  serum  albumin and  human 
gamma globulin. 
"When several  other  sera  and  plasmas  were  studied  by reaction  with  the 
anti-CLM 500S serum in serum-agar plates, 3 out of 7 gave a positive reaction. 
This would indicate that if any method is proposed for sterilization of plasma, 
it  should  be  completely  standardized  before  testing  in  humans.  Another 
important point of this study is that in addition to analysis of the serum for 
antibody,  skin  testing  of  the  subjects  should  always be  performed.  In  the 
absence of skin testing, there would have been little reason to doubt the utility 
and non-antigenicity of the preparation. 
It was also realized that it may be worthwhile to  study the effect of the 
ethylene oxide treatment on other sera such as guinea pig serum. When guinea 
pigs were injected with extensively modified guinea pig serum,  observations 
similar to those noted with the humans were made. However, in addition to 
the delayed type of reactions, there were also several true immediate reactions. 
This latter observation at present appears to be related to the allotypic forms 
of guinea pig gamma globulin and will  be reported  separately  (15).  Similar 
data on the antigenicity of guinea pig gamma globulin in guinea pigs have 
recently been obtained by Benacerraf and Gell (16).  The possibility that the 
delayed type skin reactions reported  here  could  be  ascribed  to  an  immune 
response  against the allotypic forms of human gamma globulin as has been 
considered previously (17)  was ruled out here.  In the study reported here 9 
out of 12 individuals gave positive delayed skin reactions after immunization 
whereas in the previous study 1 individual out of 57 injected with heat-treated 
human plasmas showed a positive delayed skin reaction with the concentrated 
protein  solutions.  This  reaction  was  not  present  when  the  individual  was 
tested with the 1-10 and 1-100 dilutions of the antigen. 
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antibody observed  in  the  humans and  guinea  pigs  confirms  the  reports  of 
Benacerraf and  Gell (18, 19). They immunized  guinea  pigs  with picrylated 
guinea pig globulin or acetylated guinea pig globulin and noted marked delayed 
reaction in the absence of circulating  antibody. In the papers  of these latter 
workers, (18-20) as well as those of Pappenheimer (21), and Salvin (22, 23), the 
question  of whether cellular immunity is a  stage in antibody production  has 
been  discussed.  From the results  presented  here  with humans, this did not 
seem to be the case. Repeated injections  over  a  period  of  1~ years of the 
modified serum  proteins did not produce  detectable circulating  antibody in 
the most exquisitely  sensitive  individuals.  From this single observation,  one 
cannot generalize, but it would appear that in humans it is possible to have 
delayed sensitivity persist  in  the  absence  of  circulating  antibody. This  is 
certainly easier to produce  with homologous serum proteins rather than with 
heterologous proteins  as discussed by Benacerraf  and Gell (19). 
It is difficult to explain  the cause of the transient immediate reactions  in 
both humans and guinea pigs. The material which caused "histamine" libera- 
tion  and  change  in  vascular  permeability is  unknown.  However,  from the 
work of Ishizaka and Ishizaka (24) it appears  that aggregated  human gamma 
globulin prepared by various  procedures  can induce  skin reactions  in normal 
guinea pigs similar to those produced by soluble antigen-antibody complexes. 
As suggested by these workers, the change in molecular  configurations of the 
gamma globulin may be responsible in part for the biologic activity. Physio- 
chemical  and  immunochemical  studies  of  the  CLM 500S preparation have 
indicated the presence of aggregated  and altered gamma globulin which may 
account for the odd immediate inflammatory reactions. 
It has been suggested by Waksman (25, 26) that many autoimmune reactions 
fall into the classification of delayed cellular reactions. One of the explanations 
advanced to account for the immune responses is that there is some change in 
the  structure  of  the  tissue  protein,  leading  to  the  production of  a  protein 
foreign  to  the host.  The  experiments  of Benacceraf  and  Gell and  the ones 
reported here would support the concept that delayed reactions in the absence 
of antibody can be produced  against modified homologous proteins. 
From the histological pictures presented in Figs. 3 and 4, the delayed reac- 
tions appear to consist of an almost pure mononuclear  cell infiltration. This, 
as well as the initial polymorphonuclear  cell predominance  would  make the 
observed  reaction compatible  with the tuberculin type of reaction.  Although 
intense reactions were observed in many individuals, at no time was there any 
necrosis or tissue damage. 
The  transfer of  the  sensitivity to  normal donors  by extracts of sensitive 
leukocytes confirms  Lawrence's  observations  on  the  transfer  in  man  with 
other systems such as diphtheria toxin (27), tuberculin (5), and streptococcal 
proteins (28). However, in these latter reports,  the question was always raised PAUL H.  MAURER  1037 
whether the recipients may have been sensitized by the pre-cell transfer skin 
testing.  In  the  experiments  reported  here,  the  recipients  were  never  skin- 
tested until after the transfer. Moreover, the recipients could not have been 
exposed by any natural means to the E-O-treated material before skin testing. 
These experiments seem important in supporting the investigations of Lawrence 
and extending them to include other materials in addition to those of bacterial 
and fungal origin (29).  It is also of some interest that the recipients were still 
delayedly hypersensitive a year after the initial transfer and skin testing. 
SUMMARY 
The antigenicity of an ethylene oxide-treated human serum in humans has 
been studied. The immune response to the material had many of the charac- 
teristics of a delayed cellular skin reaction. Even after repeated immunizations 
by intradermal skin testing over a period of 1~ years, no detectable antibody 
could be found in the sera. The antigenicity has been shown to be associated 
with  drastic  alteration  of  the  homologous serum  proteins  as  evidenced by 
(a)  the  formation of new proteins,  and  (b)  the  poor  cross-reactions  of  the 
modified serum proteins with antisera against normal human serum albumin 
and normal human gamma globulin. 
The delayed hypersensitivity was transferable to normal recipients by either 
viable  or  killed  leukocytes.  The  implications  of  these  findings  have  been 
discussed with respect  to the problem  of sterilization of sera,  the tuberculin 
reaction, and autoimmune phenomena. 
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EXPLANATION  OF PLATES 
PLATE 105 
FIG. 1.  Flare-up reaction at initial skin test site observed in volunteer 105  1 week 
after skin testing. Dotted area refers to size of reactions the evening before recording. 
Arrows  indicate other skin test sites of  0.15  m NaCt and 5 per cent human serum 
albumin. 
FIG. 2.  Skin reaction observed 24 hours after testing with CLM serum. Note four 
other negative reactions (normal human serum, 5 per cent human serum albumin, 
1 per cent human gamma globulin, and 0.15 M NaC1). THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 113  PLATE  105 
(Maurer: Immunologic studies) PLATE 106 
FIG.  3.  Histo]ogical section  (hematoxylin and  eosin)  of  biopsy of  24  hour  skin 
reaction of sensitized individual. Note almost pure lymphocytic response.  X  500. 
FIG.  4.  Histological section  (hematoxylin and  eosin)  of  biopsy of  24  hour  skin 
reaction of normal individual iniected with extract of leukocytes from sensitive donor. 
Note again marked lymphocytic infiltration,  X  500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 113  PLATE  106 
(Maurer: Immunologic studies) PLATE  107 
FIG.  S.  Patterns  of  reaction  in  agar  of  CLM  serum  and  normal  human  serum 
with rabbit anti-CLM serum 500S. 
FIG. 6.  Patterns of reactions in medium  of normal human serum  25 per cent and 
agar  of  CLM  serum  and  anti-CLM  serum  500S.  Negative  reactions  noted  with  a 
plasma  treated  with ethylene  oxide  under mild  conditions. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL, 113  PLATE  107 
(Maurer: Immunologic studies) 